An Open-Label, Survey-Based, Multicenter Study to Determine Patient Satisfaction With Single-Use Prefilled Avonex PEN Autoinjector in Multiple Sclerosis Patients.
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms ASPECT
- Sponsors Biogen Idec
- 31 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Mar 2012 Actual patient number 89 added as reported by ClinicalTrials.gov.
- 15 Mar 2012 Planned end date changed from 1 Apr 2012 to 1 May 2012 as reported by ClinicalTrials.gov.